Sequential administration of anti-VEGF therapy after craniospinal
irradiation and intrathecal chemotherapy for the treatment of central
nervous system AML relapse after allo-HSCT: a case report and literature
There have been few reports on the treatment of central nervous system
(CNS) acute myeloid leukemia (AML) relapse. This case study demonstrates
that bevacizumab may be a viable treatment option when combined with IT
chemotherapy as maintenance therapy for those with CNS leukemia.